Industry Intelligence for Technology, Industrial, and Emerging Sectors
Independent market intelligence and strategic analysis helping organizations understand technology adoption, industry trends, and competitive dynamics.
Trusted by Global Industry Leaders
Strategic Intelligence
In-depth market intelligence across global technology, industrial, and emerging sectors supporting strategic decision making.
Automation & Robotics
AI-enabled robotics, predictive maintenance and intelligent automation reshaping manufacturing operations.
Explore Research →Semiconductors
Advanced packaging, AI workloads and global fabrication investments reshaping semiconductor markets.
Explore Research →Energy & Power
Renewable integration, hydrogen investment and grid modernization accelerating energy transformation.
Explore Research →Agriculture Technology
Precision farming, automation and agrivoltaics expanding across global agricultural systems.
Explore Research →Healthcare Technologies
AI diagnostics, biotechnology and digital health platforms redefining healthcare delivery.
Explore Research →Advanced Materials
Next-generation materials enabling innovation across electronics, batteries and industrial manufacturing.
Explore Research →Featured Market Research
Predictive Maintenance Robotics Market
AI-enabled inspection and maintenance robots are expanding across industrial facilities as manufacturers prioritize predictive maintenance and operational uptime.
5G NTN Backhaul Market
Satellite backhaul is emerging as a key component of 5G Non-Terrestrial Networks, enabling coverage expansion for rural connectivity, maritime communications, and aviation networks.
Artificial Intelligence (AI) In Oil And Gas Market
AI-driven analytics and automation are enabling oil and gas companies to optimize drilling operations, enhance reservoir management, and improve predictive maintenance across upstream and downstream assets.
Thought Leadership
Insights and analysis from our research team on emerging technologies, market developments, and competitive dynamics.
Press Releases
Official announcements and market research updates from Knowledge Sourcing Intelligence (KSI).
Companion Diagnostics For Targeted Therapies Market is expected to reach USD 15.1 billion by 2031
In 2025, there will be a rapid expansion of the companion diagnostics-targeted therapies ecosystem due to a combination of growing precision medicine use and new and improved regulatory compliance with organisations such as the U.S. Food and Drug Administration, which will be the driving force behind this development. Companion diagnostics (CDx) are in vitro diagnostic (IVD) devices designed to help physicians use targeted drugs by identifying the required biomarkers in patients before they begin treatment.The U.S. FDA approved 46 new drugs in 2025, primarily drugs associated with drug treatment strategies based on biomarkers, and numerous new companion diagnostic devices to accompany these drugs to diagnose patients with malignant neoplasms of the lung, breast, and ovary to ensure appropriate patient selection for such therapies as immunotherapy and kinase inhibitors.Regulatory strategies aimed at reclassifying specific tests for companion diagnostics are being discussed to expedite test approvals and thus provide greater access to testing for patients, which will support the continuing growth of the convergence of the diagnostic and therapeutic markets.
Biomarker-Based Disease Detection Market is anticipated to surpass US$ 107.1 billion in 2031 at a CAGR of 11.0%
The global biomarker-based disease detection market is growing rapidly, driven by rising demand for personalized medicine, early disease diagnosis, and targeted therapies. Advances in genomics, immunoassays, and next-generation sequencing are improving diagnostic accuracy. North America leads the market, while Asia Pacific shows strong growth potential due to expanding healthcare infrastructure.
Precision Medicine Diagnostics Solutions Market is expected to reach USD 122.6 billion by 2031
According to government health organisations, precision diagnostics play a key role in making clinical decisions. For example, genomic sequencing and biomarker-based tests can help determine which therapies are chosen. The National Cancer Institute states that national laboratory networks now utilize standardized next-generation sequencing (NGS) assays to match patients with targeted therapies during clinical trials such as MATCH and ComboMATCH, increasing the accuracy of treatment distribution. Additionally, recent government-funded studies, notably California’s precision medicine initiative, have enrolled more than 220,000 individuals in research studies involving genomics and screening, thus increasing the volume of real-life diagnostic data. These regulatory and research developments indicate that diagnostics are transitioning to multi-biomarker, data-driven platforms integrated into the clinical workflow.
The KSI Research Advantage
Knowledge Sourcing Intelligence delivers independent market intelligence across technology, industrial, and emerging sectors. Our research combines primary interviews, proprietary datasets, and structured forecasting models to help organizations make informed strategic decisions.
Research Coverage
8,000+ market research reports covering global industries including semiconductors, energy, automation, healthcare, agriculture, and advanced materials.
Industry Expertise
Research led by analysts specializing in sector-specific intelligence, technology adoption trends, competitive benchmarking, and investment analysis.
Strategic Forecasting
Multi-year market forecasts supported by quantitative modeling, regulatory analysis, and global industry tracking across more than 60 countries.
Need Custom Market Intelligence?
Speak with our analysts about custom research, market sizing, or competitive analysis.